Related references
Note: Only part of the references are listed.Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta-analysis
Bao-Hong Yuan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection: A Systematic Review and Meta-analysis
Won-Mook Choi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis
Shravan Dave et al.
HEPATOLOGY (2021)
High level of medication adherence is required to lower mortality in patients with chronic hepatitis B taking entecavir: A nationwide cohort study
Jayoun Lee et al.
JOURNAL OF VIRAL HEPATITIS (2021)
No difference in hepatocellular carcinoma risk in chronic hepatitis B patients treated with tenofovir vs entecavir: evidence from an updated meta-analysis
Jie Yuan et al.
Aging-US (2021)
Validation of the HCC-RESCUE score to predict hepatocellular carcinoma risk in Caucasian chronic hepatitis B patients under entecavir or tenofovir therapy
Fatih Guzelbulut et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis
Xinhui Wang et al.
GUT AND LIVER (2020)
Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China
Terry Cheuk-Fung Yip et al.
GASTROENTEROLOGY (2020)
Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
Yao-Chun Hsu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naive patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis
Sung Won Lee et al.
GUT (2020)
No Difference in Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection Treated With Entecavir vs Tenofovir
Hyunwoo Oh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Tenofovir may be superior to entecavir for preventing hepatocellular carcinoma and mortality in individuals chronically infected with HBV: a meta-analysis
Yu-Xian Teng et al.
GUT (2020)
Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis
Min Li et al.
HEPATOLOGY INTERNATIONAL (2020)
Incidence and predictors of hepatocellular carcinoma beyond year 5 of entecavir therapy in chronic hepatitis B patients
Fai-Meng Sou et al.
HEPATOLOGY INTERNATIONAL (2020)
Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis
Ingyoon Ha et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta-analysis
Lihu Gu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review
Cheng-Hao Tseng et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Tenofovir Treatment Has Lower Risk of Hepatocellular Carcinoma than Entecavir Treatment in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis
Hairong Liu et al.
LIVER CANCER (2020)
Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis
Cheng-Hao Tseng et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis
Zeyu Zhang et al.
BMC CANCER (2019)
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea
Seung Up Kim et al.
JOURNAL OF HEPATOLOGY (2019)
Notice of Retraction and Replacement. Choi et al. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a Korean nationwide cohort study. JAMA Oncol. 2019;5(1):30-36
Young-Suk Lim et al.
JAMA ONCOLOGY (2019)
Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B A Korean Nationwide Cohort Study
Jonggi Choi et al.
JAMA ONCOLOGY (2019)
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entercavir and tenofovir
David Sooik Kim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea
Jung Hwan Yu et al.
HEPATOLOGY RESEARCH (2018)
Clinical utility of hepatitis B surface antigen kinetics in treatment-naive chronic hepatitis B patients during long-term entecavir therapy
Tien-Ching Lin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B
Yao-Chun Hsu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis
Eui Joo Kim et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment
Jung Hee Kim et al.
HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response
G. -A. Kim et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Peginterferon is preferable to entecavir for prevention of unfavourable events in patients with HBeAg-positive chronic hepatitis B: A five-year observational cohort study
S. -Y. Li et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis
Masako Okada et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t) ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study
I. -T. Wu et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Risk score model for the development of hepatocellular carcinoma in treatment-naive patients receiving oral antiviral treatment for chronic hepatitis B
Won Sohn et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2017)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
Tung-Hung Su et al.
LIVER INTERNATIONAL (2016)
Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
Jaemin Lee et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2016)
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection
Maria Buti et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy
C. S. Coffin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine
Young-Suk Lim et al.
GASTROENTEROLOGY (2014)
Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B
A. K. Singal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Alla Arzumanyan et al.
NATURE REVIEWS CANCER (2013)
Comparison of the Efficacy of Entecavir and Tenofovir in Chronic Hepatitis B
Fatih Guzelbulut et al.
HEPATO-GASTROENTEROLOGY (2012)
Network meta-analysis, electrical networks and graph theory
Gerta Ruecker
RESEARCH SYNTHESIS METHODS (2012)
Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma
Michael C. Kew
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2010)
Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke
Vincent Thijs et al.
EUROPEAN HEART JOURNAL (2008)
Natural history of hepatitis-related hepatocellular carcinoma
David Yiu-Kuen But et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)